Cohere-Med

Clinical variation inherent in subjective medical judgments of doctors/nurses hold back improvements in clinical outcomes. Having timely and optimal actionable information can save lives in acute care scenarios. To address this, Cohere-Med uses data science to tackle patient decompensation (an area with high clinical variability) in hospitals. They licensed clinical AI solutions developed by Duke University for use at the Duke Health System to target two problems that every hospital- globally- struggles with sepsis and cardiac decompensation. Sepsis and cardiac-related conditions, apart from increasing mortality and drastically reducing the patient's quality of life- should they survive it- also negatively impact hospital finances.

The company's platform ensures timely and consistent treatment at scale in a hospital. The platform will consist of an Electronic Health Record (EHR) data ingestion engine that feeds Duke's AI models and a user interface to help clinical teams get alerts and track treatments for sepsis and cardiac decompensation. Cohere-Med achieved commercial traction in January 2023 by proving to a health system in Ohio, Summa Health, the positive impact they can bring to their clinical operations (which led to a paid pilot).